CNBC Investing Club

We are adding to our position in this drug stock

David Ricks, CEO, Eli Lilly
Scott Mlyn | CNBC

(This article was sent first to members of the CNBC Investing Club with Jim Cramer. To get the real-time updates in your inbox, subscribe here.)

Shortly before the closing bell, we will be buying 75 shares of Eli Lilly (LLY) at roughly $261.75. Following the trade, the Charitable Trust will own 325 shares of Eli Lilly. This buy will increase Eli Lilly's weight in the portfolio from about 1.56% to 2.02%.

More In CNBC Investing Club Newsletter

CNBC Investing ClubAMD shares jump after an analyst upgrade. We also think the stock is a buy
CNBC Investing ClubWe're adding an appliance maker to our Bullpen as we look for new stocks to buy
CNBC Investing ClubWalmart's lousy quarter has us looking to exit our position in the retailer